Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Atopic Dermatitis
In brief
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Key facts
- Study ID
- NCT06947993
- Run by
- Novartis Pharmaceuticals
- People needed
- 224
- Starts
- 2025-05-16
- Expected to finish
- 2028-12-22
- Last updated by the study team
- 2025-12-22
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Birmingham, Alabama, United States (enrolling)
- Novartis Investigative Site — Fort Smith, Arkansas, United States (enrolling)
- Novartis Investigative Site — Fountain Valley, California, United States (enrolling)
- Novartis Investigative Site — Los Angeles, California, United States (enrolling)
- Novartis Investigative Site — Sacramento, California, United States (enrolling)
- Novartis Investigative Site — Santa Ana, California, United States (enrolling)
- Novartis Investigative Site — Santa Monica, California, United States (enrolling)
- Novartis Investigative Site — Washington D.C., District of Columbia, United States (enrolling)
- Novartis Investigative Site — Miami, Florida, United States (enrolling)
- Novartis Investigative Site — Atlanta, Georgia, United States (enrolling)
- Novartis Investigative Site — Macon, Georgia, United States (enrolling)
- Novartis Investigative Site — Louisville, Kentucky, United States (enrolling)
- Novartis Investigative Site — Brighton, Massachusetts, United States (enrolling)
- Novartis Investigative Site — Troy, Michigan, United States (enrolling)
- Novartis Investigative Site — Saint Joseph, Missouri, United States (enrolling)
- Novartis Investigative Site — Brooklyn, New York, United States (enrolling)
- Novartis Investigative Site — Arlington, Texas, United States (enrolling)
- Novartis Investigative Site — Cypress, Texas, United States (enrolling)
- Novartis Investigative Site — Dallas, Texas, United States (enrolling)
- Novartis Investigative Site — Houston, Texas, United States (enrolling)
- Novartis Investigative Site — San Antonio, Texas, United States (enrolling)
- Novartis Investigative Site — Caba, Buenos Aires, Argentina (enrolling)
- Novartis Investigative Site — Caba, Buenos Aires, Argentina (enrolling)
- Novartis Investigative Site — Rosario, Santa Fe Province, Argentina (enrolling)
- Novartis Investigative Site — Birmingham, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.